Literature DB >> 25220236

SRSF2 promotes splicing and transcription of exon 11 included isoform in Ron proto-oncogene.

Heegyum Moon1, Sunghee Cho1, Tiing Jen Loh1, Hyun Kyung Oh1, Ha Na Jang1, Jianhua Zhou2, Young-Soo Kwon3, D Joshua Liao4, Youngsoo Jun1, Soohyun Eom1, Claudia Ghigna5, Giuseppe Biamonti5, Michael R Green6, Xuexiu Zheng1, Haihong Shen7.   

Abstract

The product of proto-oncogene Ron is a human receptor for the macrophage-stimulating protein (MSP). Upon activation, Ron is able to induce cell dissociation, migration and matrix invasion. Exon 11 skipping of Ron pre-mRNA produces Ron△165 protein that is constitutively active even in the absence of its ligand. Here we show that knockdown of SRSF2 promotes the decrease of exon 11 inclusion, whereas overexpression of SRSF2 promotes exon 11 inclusion. We demonstrate that SRSF2 promotes exon 11 inclusion through splicing and transcription procedure. We also present evidence that reduced expression of SRSF2 induces a decrease in the splicing of both introns 10 and 11; by contrast, overexpression of SRSF2 induces an increase in the splicing of introns 10 and 11. Through mutation analysis, we show that SRSF2 functionally targets and physically interacts with CGAG sequence on exon 11. In addition, we reveal that the weak strength of splice sites of exon 11 is not required for the function of SRSF2 on the splicing of Ron exon 11. Our results indicate that SRSF2 promotes exon 11 inclusion of Ron proto-oncogene through targeting exon 11. Our study provides a novel mechanism by which Ron is expressed.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Exon 11 inclusion; Pre-mRNA splicing; Proto-oncogene; Ron; SRSF2; Transcription

Mesh:

Substances:

Year:  2014        PMID: 25220236      PMCID: PMC4535357          DOI: 10.1016/j.bbagrm.2014.09.003

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  43 in total

Review 1.  Alternative RNA splicing in the nervous system.

Authors:  P J Grabowski; D L Black
Journal:  Prog Neurobiol       Date:  2001-10       Impact factor: 11.685

Review 2.  Alternative splicing and evolution: diversification, exon definition and function.

Authors:  Hadas Keren; Galit Lev-Maor; Gil Ast
Journal:  Nat Rev Genet       Date:  2010-04-08       Impact factor: 53.242

3.  Exon 11 skipping of E-cadherin RNA downregulates its expression in head and neck cancer cells.

Authors:  Sanjai Sharma; Wei Liao; Xiaofeng Zhou; David T W Wong; Alan Lichtenstein
Journal:  Mol Cancer Ther       Date:  2011-07-15       Impact factor: 6.261

4.  Specific interactions between proteins implicated in splice site selection and regulated alternative splicing.

Authors:  J Y Wu; T Maniatis
Journal:  Cell       Date:  1993-12-17       Impact factor: 41.582

5.  Expression of splicing factors in human ovarian cancer.

Authors:  D-C Fischer; Kathleen Noack; Ingo B Runnebaum; Dirk O Watermann; Dirk G Kieback; Stefan Stamm; Elmar Stickeler
Journal:  Oncol Rep       Date:  2004-05       Impact factor: 3.906

6.  Splicing regulator SC35 is essential for genomic stability and cell proliferation during mammalian organogenesis.

Authors:  Ran Xiao; Ye Sun; Jian-Hua Ding; Shengrong Lin; Dave W Rose; Michael G Rosenfeld; Xiang-Dong Fu; Xue Li
Journal:  Mol Cell Biol       Date:  2007-05-25       Impact factor: 4.272

7.  Silencing of RON receptor signaling promotes apoptosis and gemcitabine sensitivity in pancreatic cancers.

Authors:  Jocelyn Logan-Collins; Ryan M Thomas; Peter Yu; Dawn Jaquish; Evangeline Mose; Randall French; William Stuart; Rebecca McClaine; Bruce Aronow; Robert M Hoffman; Susan E Waltz; Andrew M Lowy
Journal:  Cancer Res       Date:  2010-01-26       Impact factor: 12.701

8.  Splicing factor hnRNPH drives an oncogenic splicing switch in gliomas.

Authors:  Clare V Lefave; Massimo Squatrito; Sandra Vorlova; Gina L Rocco; Cameron W Brennan; Eric C Holland; Ying-Xian Pan; Luca Cartegni
Journal:  EMBO J       Date:  2011-09-13       Impact factor: 11.598

9.  RON is a heterodimeric tyrosine kinase receptor activated by the HGF homologue MSP.

Authors:  G Gaudino; A Follenzi; L Naldini; C Collesi; M Santoro; K A Gallo; P J Godowski; P M Comoglio
Journal:  EMBO J       Date:  1994-08-01       Impact factor: 11.598

10.  The splicing factor SC35 has an active role in transcriptional elongation.

Authors:  Shengrong Lin; Gabriela Coutinho-Mansfield; Dong Wang; Shatakshi Pandit; Xiang-Dong Fu
Journal:  Nat Struct Mol Biol       Date:  2008-07-20       Impact factor: 15.369

View more
  11 in total

1.  Effects of PTCs on nonsense-mediated mRNA decay are dependent on PTC location.

Authors:  Heegyum Moon; Xuexiu Zheng; Tiing Jen Loh; Ha Na Jang; Yongchao Liu; Da-Woon Jung; Darren R Williams; Haihong Shen
Journal:  Oncol Lett       Date:  2017-01-19       Impact factor: 2.967

Review 2.  Splicing factor SRSF2-centric gene regulation.

Authors:  Kun Li; Ziqiang Wang
Journal:  Int J Biol Sci       Date:  2021-04-16       Impact factor: 6.580

Review 3.  Splicing Regulators and Their Roles in Cancer Biology and Therapy.

Authors:  Maria Roméria da Silva; Gabriela Alves Moreira; Ronni Anderson Gonçalves da Silva; Éverton de Almeida Alves Barbosa; Raoni Pais Siqueira; Róbson Ricardo Teixera; Márcia Rogéria Almeida; Abelardo Silva Júnior; Juliana Lopes Rangel Fietto; Gustavo Costa Bressan
Journal:  Biomed Res Int       Date:  2015-07-26       Impact factor: 3.411

4.  SRSF2 directly inhibits intron splicing to suppresses cassette exon inclusion.

Authors:  Heegyum Moon; Sunghee Cho; Tiing Jen Loh; Ha Na Jang; Yongchao Liu; Namjeong Choi; Jagyeong Oh; Jiyeon Ha; Jianhua Zhou; Sungchan Cho; Dong-Eun Kim; Michael B Ye; Xuexiu Zheng; Haihong Shen
Journal:  BMB Rep       Date:  2017-08       Impact factor: 4.778

5.  Decoding a cancer-relevant splicing decision in the RON proto-oncogene using high-throughput mutagenesis.

Authors:  Simon Braun; Mihaela Enculescu; Samarth T Setty; Mariela Cortés-López; Bernardo P de Almeida; F X Reymond Sutandy; Laura Schulz; Anke Busch; Markus Seiler; Stefanie Ebersberger; Nuno L Barbosa-Morais; Stefan Legewie; Julian König; Kathi Zarnack
Journal:  Nat Commun       Date:  2018-08-17       Impact factor: 14.919

6.  RRM but not the Asp/Glu domain of hnRNP C1/C2 is required for splicing regulation of Ron exon 11 pre-mRNA.

Authors:  Heegyum Moon; Ha Na Jang; Yongchao Liu; Namjeong Choi; Jagyeong Oh; Jiyeon Ha; Hyeon Ho Kim; Xuexiu Zheng; Haihong Shen
Journal:  BMB Rep       Date:  2019-11       Impact factor: 4.778

7.  PKC-Theta is a Novel SC35 Splicing Factor Regulator in Response to T Cell Activation.

Authors:  Robert Duncan McCuaig; Jennifer Dunn; Jasmine Li; Antonia Masch; Tobias Knaute; Mike Schutkowski; Johannes Zerweck; Sudha Rao
Journal:  Front Immunol       Date:  2015-11-05       Impact factor: 7.561

8.  Large-scale analysis of genome and transcriptome alterations in multiple tumors unveils novel cancer-relevant splicing networks.

Authors:  Endre Sebestyén; Babita Singh; Belén Miñana; Amadís Pagès; Francesca Mateo; Miguel Angel Pujana; Juan Valcárcel; Eduardo Eyras
Journal:  Genome Res       Date:  2016-04-13       Impact factor: 9.043

9.  RON kinase isoforms demonstrate variable cell motility in normal cells.

Authors:  Alissa Greenbaum; Ashwani Rajput; Guanghua Wan
Journal:  Heliyon       Date:  2016-09-06

10.  Identification of Regulatory-RNAs for Alternative Splicing of Ron Proto-Oncogene.

Authors:  Heegyum Moon; Xuexiu Zheng; Tiing Jen Loh; Ha Na Jang; Yongchao Liu; Da-Woon Jung; Darren R Williams; Haihong Shen
Journal:  J Cancer       Date:  2015-11-01       Impact factor: 4.207

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.